|1.||Breast Neoplasms (Breast Cancer)
|2.||Ovarian Neoplasms (Ovarian Cancer)
10/01/1994 - "We conducted a multicenter Phase II study of BMS-181339 in patients with ovarian cancer. "
10/01/1994 - "BMS-181339 Ovarian Cancer Study Group]."
10/01/1994 - "[A phase II study of BMS-181339 in patients with ovarian cancer. "
10/01/1994 - "Thus, we confirmed that BMS-181339 was a clinically useful chemotherapeutic agent in patients with ovarian cancer."
|4.||Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/01/1996 - "BMS-181339 Non-Small Cell Lung Cancer Study Group]."
05/01/1996 - "[Early phase II study of BMS-181339 (paclitaxel) in patients with non-small cell lung cancer. "
05/01/1996 - "We conducted a multi-institutional (11 facilities), early phase II study of BMS-181339 (paclitaxel), a novel anti-cancer drug, for non-small cell lung cancer (NSCLC). "